Cargando…

Dosing Recommendations for Concomitant Medications During 3D Anti-HCV Therapy

The development of direct-acting antiviral (DAA) agents has reinvigorated the treatment of hepatitis C virus infection. The availability of multiple DAA agents and drug combinations has enabled the transition to interferon-free therapy that is applicable to a broad range of patients. However, these...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badri, Prajakta S., King, Jennifer R., Polepally, Akshanth R., McGovern, Barbara H., Dutta, Sandeep, Menon, Rajeev M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761011/ https://www.ncbi.nlm.nih.gov/pubmed/26330025 http://dx.doi.org/10.1007/s40262-015-0317-8

Ejemplares similares

Drug Interactions with the Direct-Acting Antiviral Combination of Ombitasvir and Paritaprevir-Ritonavir
por: Badri, Prajakta S., et al.
Publicado: (2015)

Drug–Drug Interactions Between the Anti-Hepatitis C Virus 3D Regimen of Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and Eight Commonly Used Medications in Healthy Volunteers
por: Polepally, Akshanth R., et al.
Publicado: (2016)

Exposure–Response Relationships for Efficacy and Safety of Risankizumab in Phase II and III Trials in Psoriasis Patients
por: Khatri, Amit, et al.
Publicado: (2019)

PB2088: ABBV-383 IN COMBINATION WITH ANTI-CANCER REGIMENS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: DOSE ESCALATION AND EXPANSION
por: Valdes, Cesar Rodriguez, et al.
Publicado: (2023)

Pharmacokinetics and Dose Recommendations for Cyclosporine and Tacrolimus When Coadministered With ABT‐450, Ombitasvir, and Dasabuvir
por: Badri, P., et al.
Publicado: (2015)

Effect of Elagolix Exposure on Clinical Efficacy End Points in Phase III Trials in Women With Endometriosis‐Associated Pain: An Application of Markov Model
por: Winzenborg, Insa, et al.
Publicado: (2020)

Exposure‐Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis‐Associated Pain
por: Abbas Suleiman, Ahmed, et al.
Publicado: (2020)

Nivolumab-Induced Myasthenia Gravis Concomitant With Myocarditis, Myositis, and Hepatitis
por: Bawek, Sawyer J, et al.
Publicado: (2021)

Dose Adjustment of Concomitant Antiseizure Medications During Cenobamate Treatment: Expert Opinion Consensus Recommendations
por: Smith, Michael C., et al.
Publicado: (2022)

Validation of a quantitative systems pharmacology model of calcium homeostasis using elagolix Phase 3 clinical trial data in women with endometriosis
por: Stodtmann, Sven, et al.
Publicado: (2021)

Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low‐dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis
por: Poordad, Fred, et al.
Publicado: (2019)

Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
por: Shebley, Mohamad, et al.
Publicado: (2019)

Model-based lamotrigine clearance changes during pregnancy: clinical implication
por: Polepally, Akshanth R, et al.
Publicado: (2014)

Assessment of Clinical Drug‐Drug Interactions of Elagolix, a Gonadotropin‐Releasing Hormone Receptor Antagonist
por: Polepally, Akshanth R., et al.
Publicado: (2020)

Managing HCV Infection in Pediatric Age Group: Suggested Recommendations
por: Danish, Fazal A., et al.
Publicado: (2010)

Clinical impact of pharmacokinetic interactions between the HCV protease inhibitor simeprevir and frequently used concomitant medications
por: Marra, Fiona, et al.
Publicado: (2018)

Direct anti-HCV agents
por: Zhang, Xingquan
Publicado: (2016)

Demand Forecasting Approaches for New Contraceptive Technologies: A Landscape Review and Recommendations for Alignment
por: LaCroix, Elizabeth, et al.
Publicado: (2023)

Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing
por: Mena, Alvaro, et al.
Publicado: (2014)

Recommendations for treatment of hepatitis C. Polish Group of HCV Experts – 2015
por: Halota, Waldemar, et al.
Publicado: (2015)

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2020
por: Halota, Waldemar, et al.
Publicado: (2020)

Recommendations of the Polish Group of Experts for HCV for the treatment of hepatitis C in 2023
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2023)

New anti HCV drugs in the pipeline
por: Bourlière, Marc
Publicado: (2010)

New anti-HCV agents in the pipeline
por: Zoulim, Fabien
Publicado: (2014)

An Exploration of the Psycho-Social Benefits of Providing Sponsorship and Supporting Others in Traditional 12 Step, Self-Help Groups
por: McGovern, William, et al.
Publicado: (2021)

Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing
por: Schuh, Michael J., et al.
Publicado: (2022)

Recommendations for the treatment of hepatitis C issued by the Polish Group of HCV Experts – 2016
por: Halota, Waldemar, et al.
Publicado: (2016)

Anti-HCV prevalence in the general population of Lithuania
por: Liakina, Valentina, et al.
Publicado: (2012)

Recent advances in the anti-HCV mechanisms of interferon
por: Huang, Menghao, et al.
Publicado: (2014)

The Usefulness of Anti-HCV Signal to Cut-off Ratio in Predicting Viremia in Anti-HCV in Patients With Hepatitis C Virus Infection
por: Ranjbar Kermani, Fahimeh, et al.
Publicado: (2015)

Recommendations for clinical monitoring of patients with acid sphingomyelinase deficiency (ASMD)
por: Wasserstein, Melissa, et al.
Publicado: (2018)

Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study
por: Lin, Shih-Yi, et al.
Publicado: (2017)

The Undiagnosed Chronically-Infected HCV Population in France. Implications for Expanded Testing Recommendations in 2014
por: Brouard, Cécile, et al.
Publicado: (2015)

APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?
por: Kanda, Tatsuo, et al.
Publicado: (2018)

Consensus recommendation for a diagnostic guideline for acid sphingomyelinase deficiency
por: McGovern, Margaret M., et al.
Publicado: (2017)

Thriving in the gig economy: how to capitalize and compete in the new world of work
por: McGovern, Marion
Publicado: (2017)

Taking a Bite Out of Amalgam Concerns?: Study Shows No Renal Effects in Children
por: McGovern, Victoria
Publicado: (2008)

A Twist in the Ritalin Riddle: Drug-Related Genomic Damage Not Confirmed in Children
por: McGovern, Victoria
Publicado: (2007)

Signs for Girls: Biomarkers of Common Exposures
por: McGovern, Victoria
Publicado: (2007)

Aging: Shedding Light on Vitamin D Deficiency in Women
por: McGovern, Victoria
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_1tkqj9ju337hmlopl19a41ajbh